Breckenridge recalls
4 federal recalls on file, showing the 3 from the last 12 months. We read every CPSC, FDA, USDA and NHTSA notice for Breckenridge and put it in plain English.
Recent recalls
Breckenridge propranolol ER capsules recalled for potential metal contaminationBreckenridge Pharmaceutical is voluntarily recalling one lot of Propranolol Hydrochloride Extended-Release Capsules, USP, 60 mg, manufactured by Adare Pharma Solutions, due to potential metal contamination. The company says use of the affected lot could potentially cause lacerations, or cuts, to soft tissues in the mouth, esophagus, stomach or intestine. Breckenridge is not aware of any related adverse events, and the lot was distributed nationwide between October 26 and November 4, 2026.
SeriousFDANov 16, 2026
- Breckenridge duloxetine capsules recalled for nitrosamine impurity
Breckenridge is recalling two sizes of duloxetine delayed-release capsules, 30 mg and 60 mg, made by Towa Pharmaceutical Europe in Spain. The recall covers about 374,400 bottles distributed nationwide. The capsules contain an impurity called N-nitroso-duloxetine at a level above the FDA's recommended interim limit. No injuries have been reported.
ModerateFDAJun 17, 20262 products
- Duloxetine Delayed-Release Capsules, USP, 60 mg, 1000-Capsule bottles, Rx Only, Manufactured by: Towa Pharmaceuticals Europe, S.L. Marotrelles, (Barcelona), Spain, Manufactured for : Quallient Pharmaceuticals Health, LLC, Grand Cayman, Cayman Islands, NDC 82009-032-10.
CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit
FDADec 10, 20252 products